Gemstone BioTherapeutics, LLC — Form D
Gemstone BioTherapeutics, LLC of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-17. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-06-17
- Form: D
- Accession: 0001014100-15-000017
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.6M
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2015-06-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-242020
Issuer
- Name: Gemstone BioTherapeutics, LLC
- CIK: 0001644667
- Entity type: Limited Liability Company
- Jurisdiction: MARYLAND
- Incorporated: 2013
- Address: 180 W. OSTEND STREET, BALTIMORE, MD, 21230
- Phone: 443-873-7010
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Sharon Gerecht | Director | Baltimore, MD |
| Geoff MacKay | Director | Toronto, A6 |
| George Davis | Director | Albany, NY |
| George Davis | Executive Officer | Albany, NY |
| George Davis | Promoter | Albany, NY |
| XIN HUANG | Director | Watertown, MA |
| David Oros | Director | Bethesda, MD |
| David Oros | Promoter | Bethesda, MD |
Other filings by this issuer (1)
More